Alnylam Pharmaceuticals (ALNY)
|
24.82
+0.98 (+4.11%)
|
|
|
|
ALNY additional information
Market Data powered by QuoteMedia. Data delayed 15 minutes unless otherwise indicated. Filings and Fundamentals by Morningstar, Insiders by Vickers (USA) and SEDI(CDN), analyst ratings by Zacks.
ALNY Profile
•
Exchange
NASDAQ
•
Held by these Mutual Funds
•
Competitors
•
Executives
Mr. John K. Clarke
Founder
Chairman Chairman of Nominating & Corp. Governance Committee and Member of Audit Committee
Dr. John M. Maraganore Ph.D.
Chief Exec. Officer and Exec. Director
Mr. Barry E. Greene
Pres and Chief Operating Officer
Mr. Michael P. Mason
Principal Financial Officer
Principal Accounting Officer VP of Fin. and Treasurer
Dr. Akshay K. Vaishnaw M.D. .D.
49
Chief Medical Officer and Exec. VP
Founder
Chairman Chairman of Nominating & Corp. Governance Committee and Member of Audit Committee
Dr. John M. Maraganore Ph.D.
Chief Exec. Officer and Exec. Director
Mr. Barry E. Greene
Pres and Chief Operating Officer
Mr. Michael P. Mason
Principal Financial Officer
Principal Accounting Officer VP of Fin. and Treasurer
Dr. Akshay K. Vaishnaw M.D. .D.
49
Chief Medical Officer and Exec. VP
•
Employee Count
116
Special Offers
Competitors
ALNY earnings
Date
Actual
Expected
Prev Yr Qtr
11/5/2012
-0.38
-0.31
-0.31
8/6/2012
-0.25
-0.19
-0.33
5/3/2012
-0.25
-0.36
-0.38
